YA II PN, Ltd. 13D and 13G filings for Q BioMed Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-04 6:00 pm Sale | 2024-09-30 | 13G | QBIOMED INC QBIO | YA II PN, Ltd. | 0 0.000% | -10,207,532 (Position Closed) | Filing |
| 2023-01-03 3:45 pm Purchase | 2022-12-31 | 13G | QBIOMED INC QBIO | YA II PN, Ltd. | 10,207,532 9.990% | 9,782,030 (+2298.94%) | Filing |
| 2023-01-03 3:28 pm Purchase | 2022-12-31 | 13G | QBIOMED INC QBIO | YA II PN, Ltd. | 425,502 9.990% | 213,943 (+101.13%) | Filing |
| 2022-01-11 5:12 pm Purchase | 2021-12-31 | 13G | QBIOMED INC QBIO | YA II PN, Ltd. | 211,559 9.990% | 66,049 (+45.39%) | Filing |